Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Multiple inflammatory and immune-related protein targets refers to a broad and heterogeneous group of molecular entities that mediate the body's response to injury and pathogens. This category encompasses various classes of proteins, including cytokines like Tumor Necrosis Factor (TNF) and Interleukins (IL-1, IL-6, IL-17, IL-23), as well as intracellular signaling molecules such as Janus Kinases (JAKs) (Source: StatPearls, "Inflammation"). These proteins play critical roles in orchestrating both innate and adaptive immune responses, and their chronic overactivation is a hallmark of autoimmune and autoinflammatory diseases (Source: Nature Reviews Drug Discovery, "Targeting cytokines in inflammation"). Drugs targeting these proteins, such as monoclonal antibodies and small molecule inhibitors, are widely used to treat conditions like rheumatoid arthritis, Crohn's disease, and psoriasis. However, because this term describes a collection of targets rather than a single specific molecule, it is considered a functional grouping rather than a distinct therapeutic target.
Various mechanisms including cytokine neutralization, receptor antagonism, and intracellular signaling inhibition.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Multiple inflammatory and immune-related protein targets.